After GLP-1s, biosimilars are the new frontier in direct-to-employer plans

Fresenius Kabi will sell biosimilars directly to employers. To accomplish that, the drugmaker is working with Eversana-owned Waltz Health, which runs a marketplace that helps employers shop for better deals on prescription ...